|
Market Closed -
Swiss Exchange
09:01:17 18/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 115.10 CHF | -0.79% |
|
+2.73% | +5.02% |
| 09:50pm | Novartis' Cosentyx Gets EU Medicines Agency Panel Recommendation for Polymyalgia Rheumatica | MT |
| 09:20pm | Novartis Receives Positive Chmp Opinion for Cosentyx in Polymyalgia Rheumatica | CI |
| Market Cap | 27TCr 23TCr 22TCr 20TCr 37TCr 25,66900Cr 38TCr 2,63800Cr 1,01800Cr 13,05100Cr 1,00500Cr 98TCr 41,99200Cr | P/E 2026 * |
19.9x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 30TCr 26TCr 25TCr 22TCr 42TCr 28,69900Cr 42TCr 2,95000Cr 1,13800Cr 14,59100Cr 1,12400Cr 1,09900Cr 46,94900Cr | EV / Sales 2026 * |
5.18x | EV / Sales 2027 * | 4.81x |
| Free-Float |
91.66% | Yield 2026 * |
3.12% | Yield 2027 * | 3.26% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
London S.E.
| 0QLR | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Xetra
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -0.70% | ||
| 1 week | +2.73% | ||
| Current month | -6.62% | ||
| 1 month | -8.33% | ||
| 3 months | -2.49% | ||
| 6 months | -3.68% | ||
| Current year | +5.02% |
| 1 week | 112.46 |  | 116.98 |
| 1 month | 110.3 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.7 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +2.73% | +19.03% | +25.08% | 27TCr | |
| -0.64% | +2.44% | +49.81% | +100.06% | 1,02700Cr | |
| 0.00% | +1.63% | +54.98% | +66.13% | 65TCr | |
| +0.09% | +2.69% | +18.94% | +71.51% | 47TCr | |
| -1.22% | +3.66% | +36.44% | +38.32% | 35TCr | |
| +0.58% | +6.76% | +11.13% | +16.52% | 26TCr | |
| +0.96% | +1.45% | +38.78% | +45.47% | 21TCr | |
| +0.79% | +1.84% | -28.27% | -56.71% | 19TCr | |
| -0.03% | +4.77% | +32.52% | +99.11% | 19TCr | |
| -0.42% | -0.81% | +13.85% | -18.27% | 16TCr | |
| Average | -0.13% | +2.23% | +24.72% | +38.72% | 37.6TCr | |
| Weighted average by Cap. | -0.27% | +2.51% | +33.88% | +57.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.77TCr 5.04TCr 4.75TCr 4.32TCr 8.09TCr 5,54100Cr 8.12TCr 57TCr 22TCr 2,81700Cr 22TCr 21TCr 9,06400Cr | 6.14TCr 5.35TCr 5.06TCr 4.59TCr 8.6TCr 5,89200Cr 8.64TCr 61TCr 23TCr 2,99500Cr 23TCr 23TCr 9,63800Cr |
| Net income | 1.42TCr 1.24TCr 1.17TCr 1.07TCr 2TCr 1,36700Cr 2TCr 14TCr 5.42TCr 70TCr 5.35TCr 5.23TCr 2,23700Cr | 1.58TCr 1.37TCr 1.3TCr 1.18TCr 2.21TCr 1,51300Cr 2.22TCr 16TCr 6TCr 77TCr 5.92TCr 5.79TCr 2,47400Cr |
| Net Debt | 3.16TCr 2.75TCr 2.6TCr 2.36TCr 4.42TCr 3,03000Cr 4.44TCr 31TCr 12TCr 1,54100Cr 12TCr 12TCr 4,95700Cr | 2.79TCr 2.43TCr 2.3TCr 2.08TCr 3.91TCr 2,67600Cr 3.92TCr 28TCr 11TCr 1,36000Cr 10TCr 10TCr 4,37700Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | CHF 115.10 | -0.79% | 83,99,187 |
| 17/26/17 | CHF 116.02 | +1.52% | 24,07,734 |
| 16/26/16 | CHF 114.28 | +0.39% | 41,01,101 |
| 15/26/15 | CHF 113.84 | -0.07% | 39,54,861 |
| 14/26/14 | CHF 113.92 | +1.68% | 30,25,084 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
